糖尿病心脏自主神经病变的研究进展  

Research progress of cardiovascular autonomic neuropathy in diabetes

作　　者：罗彦相 张佳 蔡青云 郭立新[1] 潘琦 Luo Yanxiang;Zhang Jia;Cai Qingyun;Guo Lixin;Pan Qi(Department of Endocrinology,Beijing Hospital,National Center of Gerontology,Institute of Geriatric Medicine,Chinese Academy of Medical Sciences,Beijing 100730,China;Peking University Fifth School of Clinical Medicine,Beijing 100730,China;Graduate School of Peking Union Medical College and Chinese Academy of Medical Sciences,Beijing 100730,China)

机构地区：[1]北京医院内分泌科国家老年医学中心中国医学科学院老年医学研究院,100730 [2]北京大学第五临床医学院,100730 [3]中国医学科学院北京协和医学院研究生院,100730

出　　处：《中国心血管杂志》2025年第1期16-21,共6页Chinese Journal of Cardiovascular Medicine

基　　金：社会团体基金项目(BJ-2024-240)。

摘　　要：糖尿病心脏自主神经病变(CAN)是糖尿病微血管并发症之一,在糖尿病患者中的患病率不断增加。然而早期CAN常不伴明显症状,进展性CAN可增加糖尿病心血管疾病、慢性肾脏病和脑卒中的风险。人工智能的应用为早期检测CAN提供了可能。本文对CAN的流行病学、发病机制、临床表现和治疗进行综述,旨在为CAN患者提供最新的临床参考。Diabetic cardiovascular autonomic neuropathy(CAN)is one of the microvascular complications of diabetes.The prevalence of CAN in diabetes is increasing.However,early CAN often does not accompany obvious symptoms,and progressive CAN can increase the risk of cardiovascular disease,chronic kidney disease and stroke in diabetes.The application of artificial intelligence has provided the possibility for early detection of CAN.This article will review the prevalence,pathogenesis,clinical manifestation and treatment of CAN,aiming to provide an up-to-date clinical reference for CAN patients.

关 键 词：糖尿病 心脏自主神经病变 流行病学 临床表现 治疗 

分 类 号：R587.2[医药卫生—内分泌] R747.9[医药卫生—内科学]